Health Aug 20 Moderna shares surge after it says experimental mRNA cancer treatment passed key test By Associated Press
Health Aug 06 New kind of flu shot is on the way as the FDA approves Moderna's mRNA-based vaccine The shot, named mFlusiva, is intended for adults age 50 or older. By Lauran Neergaard, Associated Press
Health Jun 18 FDA panel backs first-of-its-kind flu vaccine using mRNA technology The Food and Drug Administration is evaluating Moderna's new shot, dubbed mFlusiva, for older Americans ahead of the winter flu season. By Lauran Neergaard, Matthew Perrone, Associated Press
Health Feb 18 Moderna says FDA will now consider its new mRNA flu shot after initial refusal Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the new vaccine, made with Nobel Prize-winning mRNA technology. By Lauran Neergaard, Associated Press
Nation Feb 17 Watch 6:59 U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and outside the industry concerned about the Trump administration’s… By Amna Nawaz, Courtney Norris, Bridget Craig
Aug 22 FDA approves updated COVID-19 vaccines, shots should be available in days By Lauran Neergaard, Associated Press With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses. A third U.S. manufacturer, Novavax, expects its updated vaccine version to be available a little later. Continue reading
Jul 02 U.S. government will pay Moderna $176 million to develop an mRNA bird flu pandemic vaccine By Associated Press The U.S. Department of Health and Human Services said Tuesday it is funding the development of a vaccine based on the same mRNA technology that allowed the rapid development and rollout of vaccines to protect against COVID-19. Continue reading
Mar 22 WATCH: Senators press Moderna CEO on COVID-19 vaccine price increases By Tom Murphy, Associated Press Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Continue reading
Jan 14 Watch 4:54 Why manufacturers are hiking COVID vaccine prices By John Yang, Sarah Clune Hartman Since COVID vaccines first became available in the U.S., the federal government has been buying them from manufacturers and distributing them for free. But soon, the manufacturers will be distributing them at higher prices. Jen Kates, senior vice president and… Continue watching
Oct 12 Watch 5:00 News Wrap: Parkland jury deliberates Cruz sentence, new protests sweep Iran In our news wrap Wednesday, a jury in Florida starts deliberating on whether Parkland school shooter Nikolas Cruz will be sentenced to death, seven more people were killed in Ukraine as Russia fired missiles and artillery rounds into major cities… Continue watching